Ticker: MYOK

MyoKardia Inc

$224.91

(+293.89%)

Since 2019

$

Real time stock price updated as of November 16, 2020, 5:56 PM

Disclosuredisclosure extended: false

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.

MyoKardia Inc logo

Invest in MyoKardia Inc on Stash

MyoKardia, Inc. is a clinical-stage biopharmaceutical company.

Thanks to fractional shares

Tooltip
, you can buy MyoKardia Inc stock in any dollar amount, or any other fund or stock you know on Stash.

Add a custom amount.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance.

Read more

arrow

Historical stock performance

Last 1 week

0.16%

Last 1 month

1.31%

Last 12 months

316.42%

Last 3 years

82.17%

Last 5 years

82.96%

Last 10 years

--

Last 15 years

--

Since inception

84.47%

Disclosuredisclosure extended: false

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.

MyoKardia Inc stock News

This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites.

CNBC

about 2 hours ago

FAA clears Boeing 737 Max to fly again after 20-month grounding spurred by deadly crashes

Federal regulators have cleared the Boeing 737 Max to fly again after a 20-month grounding, sparking a crisis inside the manufacturer.

Business Insider

39 minutes ago

Pfizer and BioNTech climb as 95% vaccine effectiveness tees up application for FDA approval

Pfizer and BioNTech gained in early Wednesday trading after the companies announced their experimental coronavirus vaccine was 95% effective at protecting patients against COVID-19. The updated figure comes from final analysis of trial data. Preliminary results released on November 9 showed the drug to be 90% effective in the nearly 44,000-person trial. The newest information clears the way for Pfizer and BioNTech to apply for emergency-use authorization from the Food and Drug Administration in a matter of days.

24/7 Wall Street

about 1 hour ago

Analysts Top Value Stocks to Buy Include Biotech and Technology Blue Chip Giants

During the almost 11-year run of the bull market, and since the market lows that were posted in March, one thing has remained painfully obvious to long-time investors: value stocks, and indeed the entire group, have woefully underperformed growth.

Business Insider

41 minutes ago

DOJ approves Mastercard's acquisition of Finicity, despite scrutiny over Visa's Plaid takeover

The Department of Justice (DOJ) approved Mastercard's $825 million purchase of the data aggregator, which was first announced  in June, TechCrunch reports. Finicity uses APIs to allow users to decide how their financial data is shared and who can make money decisions on their behalf. It leverages open banking to allow third-party apps access to consumer banking, transactional, and other financial data. Through the acquisition, Mastercard can offer its consumer and business customers greater control over usage of their data, strengthen its open banking platform, and provide more financial services options. 

Why invest on Stash?

Invest affordably.

You can buy pieces of stocks and funds with any dollar amount—and our subscription plans start at just $1 per month.

Enjoy unlimited trading.

Unlike other investing apps, Stash also doesn't charge any add-on trading commissions or electronic statement fees.1

Learn how to invest.

We'll help teach you how to invest confidently through tips, articles, and ongoing personalized guidance.

Stay diversified.

We can help guide you through building a custom balanced portfolio with our

Portfolio Builder Tool.

1Stash may incur ancillary fees charged by Stash and/or its custodian that are not included in the monthly Wrap-Fee.

How to buy MyoKardia Inc stock on Stash

1. Enter the amount you'd like to invest in MyoKardia Inc stock, then proceed to checkout.

Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.

Read more

2. Choose a Stash plan and set up your investment account in just a few minutes.

Stash offers three subscription plans: Stash Beginner, Stash Growth, and Stash+. Our Beginner plan starts at just $1 per month.

Read more

3. Once you’ve finished your account, your MyoKardia Inc shares will be added to your new portfolio.

Once your market order of MyoKardia Inc stock is complete, you'll officially be a shareholder of MyoKardia Inc!

Read more

MyoKardia Inc logo

Invest in MyoKardia Inc on Stash

MyoKardia, Inc. is a clinical-stage biopharmaceutical company.

Thanks to fractional shares

Tooltip
, you can buy MyoKardia Inc stock in any dollar amount, or any other fund or stock you know on Stash.

Add a custom amount.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance.

Read more

arrow

147k+ reviews on App Store and Google Play™ Store

Over 3 million Americans use Stash to invest, save, and spend.

This is not an endorsement or a statement of satisfaction.

App StorePlay Store